111 related articles for article (PubMed ID: 15065628)
1. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Bowlin SJ; Koro CE
Mayo Clin Proc; 2004 Apr; 79(4):572, 575; author reply 575-7. PubMed ID: 15065628
[No Abstract] [Full Text] [Related]
2. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Bell DS
Mayo Clin Proc; 2004 Apr; 79(4):572; author reply 575-7. PubMed ID: 15065627
[No Abstract] [Full Text] [Related]
3. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Mikhail NE; Wali S; Cope D
Mayo Clin Proc; 2004 Apr; 79(4):571-2; author reply 575-7. PubMed ID: 15065626
[No Abstract] [Full Text] [Related]
4. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Jamieson A; Abousleiman Y
Mayo Clin Proc; 2004 Apr; 79(4):571; author reply 575-7. PubMed ID: 15065625
[No Abstract] [Full Text] [Related]
5. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
[No Abstract] [Full Text] [Related]
6. [Heart failure with thiazolidinedione treatment: what do we know today?].
Erdmann E
Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone-induced anasarca without heart failure: capillary leakage?
Dagdelen S; Kurt M; Aydin K; Bayraktar M
Hormones (Athens); 2008; 7(2):180-3. PubMed ID: 18477557
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Kermani A; Garg A
Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R
Diabetes Care; 2004 Jan; 27(1):256-63. PubMed ID: 14693998
[No Abstract] [Full Text] [Related]
10. Do thiazolidinediones cause congestive heart failure?
Kennedy FP
Mayo Clin Proc; 2003 Sep; 78(9):1076-7. PubMed ID: 12962160
[No Abstract] [Full Text] [Related]
11. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.
Hartung DM; Touchette DR; Bultemeier NC; Haxby DG
Pharmacotherapy; 2005 Oct; 25(10):1329-36. PubMed ID: 16185176
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.
Patel RR
Cardiol Rev; 2009; 17(3):132-5. PubMed ID: 19384087
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association: response to Nesto.
Elasy TA; Griffin M
Diabetes Care; 2004 Aug; 27(8):2096; author reply 2096. PubMed ID: 15277462
[No Abstract] [Full Text] [Related]
14. Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms.
Wang F; Vergara C; Carabino J; Desilets A; Vasquez R
Am J Health Syst Pharm; 2004 Aug; 61(15):1604-8. PubMed ID: 15372837
[No Abstract] [Full Text] [Related]
15. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
Buckingham RE; Hanna A
Diabetes Obes Metab; 2008 Apr; 10(4):312-28. PubMed ID: 18333890
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinedione-induced edema in patients with heart failure.
Stroup JS
Am J Health Syst Pharm; 2007 Dec; 64(23):2426-30; author reply 2430. PubMed ID: 18029947
[No Abstract] [Full Text] [Related]
17. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
[TBL] [Abstract][Full Text] [Related]
18. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure.
Erdmann E; Wilcox RG
Eur Heart J; 2008 Jan; 29(1):12-20. PubMed ID: 18167366
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone and heart failure: long-term vigilance.
Singh N
J Cardiovasc Pharmacol Ther; 2004 Mar; 9(1):21-5. PubMed ID: 15094965
[TBL] [Abstract][Full Text] [Related]
20. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?
Baskin S; Neher JO; Dodson S; Hoffman R
J Fam Pract; 2005 Aug; 54(8):723-4. PubMed ID: 16061064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
